Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-30 Sale | 2024-02-01 4:17 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 794 | $27.25 | $21,637 | 71,189 (Direct) | View |
| 2024-01-08 Sale | 2024-01-10 4:04 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 3,395 | $28.85 | $97,960 | 71,983 (Direct) | View |
| 2023-04-17 Sale | 2023-04-19 4:09 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 61,923 | $51.42 | $3,183,830 | 518,859 (Direct) | View |
| 2023-01-31 Sale | 2023-02-02 4:18 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 812 | $45.63 | $37,050 | 75,378 (Direct) | View |
| 2023-01-10 Sale | 2023-01-12 4:38 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 1,085 | $43.58 | $47,288 | 76,190 (Direct) | View |
| 2023-01-09 Sale | 2023-01-11 6:14 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 835 | $41.66 | $34,783 | 77,275 (Direct) | View |
| 2022-10-17 Sale | 2022-10-19 4:09 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 6,901 | $55 | $379,572 | 664,691 (Direct) | View |
| 2022-09-20 Sale | 2022-09-22 4:38 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 1,176 | $55 | $64,680 | 547,658 (Direct) | View |
| 2022-04-13 Sale | 2022-04-15 4:02 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 2,276 | $45.17 | $102,811 | 479,710 (Direct) | View |
| 2022-04-05 Sale | 2022-04-07 4:03 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 5 | $45 | $225 | 481,986 (Direct) | View |
| 2022-02-10 Sale | 2022-02-11 4:11 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 17,935 | $45.03 | $807,559 | 481,991 (Direct) | View |
| 2022-02-01 Sale | 2022-02-03 4:57 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 779 | $40 | $31,162 | 61,110 (Direct) | View |
| 2022-01-07 Sale | 2022-01-11 4:19 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 885 | $38.52 | $34,095 | 115,889 (Direct) | View |
| 2021-09-02 Sale | 2021-09-03 4:06 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 3,363 | $45.01 | $151,375 | 433,381 (Direct) | View |
| 2021-07-08 Sale | 2021-07-12 4:26 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 9,234 | $45.19 | $417,274 | 592,046 (Direct) | View |
| 2021-02-01 Sale | 2021-02-02 6:23 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 778 | $56.96 | $44,312 | 48,374 (Direct) | View |
| 2021-01-05 Sale | 2021-01-07 5:05 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 772 | $62.37 | $48,150 | 38,952 (Direct) | View |
| 2020-07-07 Sale | 2020-07-09 4:08 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 30,625 | $55.12 | $1,688,037 | 378,061 (Direct) | View |
| 2019-07-05 Sale | 2019-07-09 4:54 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 15,312 | $44.74 | $685,097 | 410,280 (Direct) | View |
| 2019-06-28 Sale | 2019-07-02 6:46 pm | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 181,667 | $45 | $8,175,015 | 567,721 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Option Award | 2024-02-16 4:10 pm | N/A 2034-02-14 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 66,200 | $0 | 137,389 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-19 4:09 pm | N/A 2026-01-03 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 61,923 | $30.86 | 518,859 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-09 4:56 pm | N/A 2033-01-04 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 53,250 | $0 | 114,360 (Direct) | View |
| 2022-10-17 Exercise | 2022-10-19 4:09 pm | N/A 2026-01-03 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 6,901 | $30.86 | 664,691 (Direct) | View |
| 2022-09-20 Exercise | 2022-09-22 4:38 pm | N/A 2026-01-03 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 1,176 | $30.86 | 547,658 (Direct) | View |
| 2022-04-13 Exercise | 2022-04-15 4:02 pm | N/A 2027-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 2,276 | $11.23 | 479,710 (Direct) | View |
| 2022-04-05 Exercise | 2022-04-07 4:03 pm | N/A 2027-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO | 5 | $11.23 | 481,986 (Direct) | View |
| 2022-02-10 Exercise | 2022-02-11 4:11 pm | N/A 2027-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 2,282 | $11.23 | 481,991 (Direct) | View |
| 2022-02-10 Exercise | 2022-02-11 4:11 pm | N/A 2028-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 15,653 | $18.01 | 481,991 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-11 4:19 pm | N/A 2032-01-06 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 68,400 | $0 | 115,889 (Direct) | View |
| 2021-09-02 Exercise | 2021-09-03 4:06 pm | N/A 2028-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 3,363 | $18.01 | 433,381 (Direct) | View |
| 2021-07-08 Exercise | 2021-07-12 4:26 pm | N/A 2027-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 2,000 | $11.23 | 592,046 (Direct) | View |
| 2021-07-08 Exercise | 2021-07-12 4:26 pm | N/A 2028-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 7,234 | $18.01 | 592,046 (Direct) | View |
| 2021-01-06 Option Award | 2021-01-08 5:17 pm | N/A 2031-01-05 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 69,700 | $0 | 108,652 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:08 pm | N/A 2027-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 13,125 | $11.23 | 378,061 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:08 pm | N/A 2028-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 17,500 | $18.01 | 378,061 (Direct) | View |
| 2020-01-29 Option Award | 2020-01-31 4:44 pm | N/A 2030-01-28 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 69,700 | $0 | 99,224 (Direct) | View |
| 2019-07-05 Exercise | 2019-07-09 4:54 pm | N/A 2027-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 6,562 | $11.23 | 410,280 (Direct) | View |
| 2019-07-05 Exercise | 2019-07-09 4:54 pm | N/A 2028-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 8,750 | $18.01 | 410,280 (Direct) | View |
| 2019-06-28 Exercise | 2019-07-02 6:46 pm | N/A 2023-05-15 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 57,917 | $10.85 | 567,721 (Direct) | View |
| 2019-06-28 Exercise | 2019-07-02 6:46 pm | N/A 2027-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 26,250 | $11.23 | 567,721 (Direct) | View |
| 2019-07-01 Exercise | 2019-07-02 6:46 pm | N/A 2023-05-15 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 77,143 | $0 | 567,721 (Direct) | View |
| 2019-06-28 Exercise | 2019-07-02 6:46 pm | N/A 2024-01-28 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 80,000 | $27.05 | 567,721 (Direct) | View |
| 2019-07-01 Exercise | 2019-07-02 6:46 pm | N/A 2028-01-02 | PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO | 17,500 | $18.01 | 567,721 (Direct) | View |